Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05595980 · ClinicalTrials.gov registry record · NA

The Effects of a Novel Probiotic on Gastrointestinal Health in Generally Healthy Adults

A NA study of Digestive Health and Gastrointestinal Health, sponsored by BIO-CAT Microbials.

Completed
Registry status
NA
Development phase
80
Enrollment target
1
Study location

NCT05595980 is a NA study of Digestive Health and Gastrointestinal Health that has completed, run by BIO-CAT Microbials. The registered enrollment target is 80 participants, above the 70-participant average among 6 other Digestive Health trials with a reported enrollment target (14% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05595980, a NA study of Digestive Health and Gastrointestinal Health, has completed, sponsored by BIO-CAT Microbials.

COMPLETED
Registry status
NA
Development phase
80 participants
Enrollment target
1
Study location

Study Summary

The primary objective of this study is to investigate the effect of an oral probiotic (Bacillus sp. spore preparation) on abdominal bloating, flatulence, and burping in generally healthy adults. Secondary outcomes include intestinal barrier integrity and fecal microbiome properties (taxonomical structure, diversity, and function).

Interventions

  • DIETARY_SUPPLEMENT Placebo
  • DIETARY_SUPPLEMENT Probiotic

Study Locations (1)

Illinois

  • Biofortis Clinical Research, Inc. - Addison

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2022-09-19
Est. Completion 2023-02-03
Phase NA

Sponsor

BIO-CAT Microbials

3 total trials

What the Registry Record Tells You About NCT05595980

The ClinicalTrials.gov registry entry for NCT05595980 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 70-participant average among 6 other Digestive Health trials with a reported enrollment target (14% higher). The listed sponsor is BIO-CAT Microbials, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Digestive Health appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT05595980 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT05595980 about?

NCT05595980 is a clinical study titled "The Effects of a Novel Probiotic on Gastrointestinal Health in Generally Healthy Adults". The primary objective of this study is to investigate the effect of an oral probiotic (Bacillus sp. spore preparation) on abdominal bloating, flatulence, and burping in generally healthy adults. Secondary outcomes include intestinal barrier integrity and fecal microbiome properties (taxonomical stru...

What is the current status of trial NCT05595980?

This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2022-09-19. Estimated completion is 2023-02-03.

What conditions does trial NCT05595980 study?

This clinical trial studies the following conditions: Digestive Health, Gastrointestinal Health, Immune Health.

What interventions are being tested in trial NCT05595980?

The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Probiotic (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT05595980?

This trial is sponsored by BIO-CAT Microbials, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05595980 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Digestive Health

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.